Related Experiment Video
Updated: Dec 23, 2025

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
[The NMD escape mechanism and its application in disease therapy]
Miao Miao Cheng1, Yan Yan Cao1
1Department of Medical Genetics, Capital Institute of Pediatrics, Beijing 100020, China.
Abstract:
Nonsense-mediated mRNA decay (NMD) refers to the degradation of mRNA due to the presence of premature stop codon (PTC) on mRNA under pathological or physiological conditions. NMD is widely considered an mRNA-specific quality control process. Recently it was discovered that some PTCs do not trigger NMD in a variety of diseases - a process known as NMD escape; however, its exact mechanism remains unclear. At present, there are two widely accepted mechanistic hypotheses during NMD escape. The first is PTC read-through, in which protein translation undergoes PTC until the normal stop codon is encountered, producing a full-length protein. The second is translation reinitiation, in which protein translation recommences at the potential start codon downstream of PTC and terminates at the stop codon, producing an N-terminal truncated protein. Currently, an increasing number of drugs or small molecules that use PTC read-through have been successfully applied to treat nonsense variation-associated diseases. In this review, we summarize the NMD mechanism and discuss the application and progress in our understanding of NMD escape in disease therapy. This review should provide a useful framework to advance current understanding of the research and application of NMD escape.
Insights
Nonsense-mediated mRNA decay (NMD) degrades faulty mRNA. NMD escape, where faulty mRNAs evade degradation, offers new therapeutic strategies for genetic diseases by restoring protein function.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Nonsense-mediated mRNA decay (NMD) is a crucial cellular quality control mechanism that eliminates aberrant messenger RNAs (mRNAs) containing premature termination codons (PTCs).
- NMD prevents the production of potentially harmful truncated proteins.
- Recent findings reveal that certain PTCs can evade NMD, a phenomenon termed 'NMD escape', which is observed in various diseases.
Purpose of the Study:
- To review the fundamental mechanisms of NMD.
- To explore the emerging concept of NMD escape and its underlying molecular hypotheses.
- To discuss the therapeutic implications and advancements in utilizing NMD escape for treating genetic disorders.
Main Methods:
- Literature review of NMD pathways and NMD escape mechanisms.
- Analysis of current research on therapeutic strategies targeting NMD escape.
- Synthesis of existing knowledge on PTC read-through and translation reinitiation.
Main Results:
- Two primary hypotheses for NMD escape are PTC read-through (producing full-length proteins) and translation reinitiation (producing N-terminal truncated proteins).
- Therapeutic strategies leveraging PTC read-through are increasingly successful in treating diseases caused by nonsense mutations.
- Understanding NMD escape mechanisms is critical for developing novel treatments.
Conclusions:
- NMD escape represents a significant biological process with considerable therapeutic potential.
- Targeting NMD escape pathways, particularly PTC read-through, offers promising avenues for treating genetic diseases.
- Further research into NMD escape mechanisms will accelerate the development of effective therapies for nonsense variation-associated conditions.
More Related Videos
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Nuclear Export of mRNA
Gene Therapy
Experimental RNAi

